Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Working Capital Changes: 2022-2025

Historic Other Working Capital Changes for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to -$480,000.

  • Day One Biopharmaceuticals' Other Working Capital Changes fell 133.22% to -$480,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 73.83%. This contributed to the annual value of $4.8 million for FY2024, which is 44.10% up from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Other Working Capital Changes stood at -$480,000 for Q3 2025, which was down 143.60% from $1.1 million recorded in Q2 2025.
  • Day One Biopharmaceuticals' Other Working Capital Changes' 5-year high stood at $3.9 million during Q2 2024, with a 5-year trough of -$1.5 million in Q3 2022.
  • In the last 3 years, Day One Biopharmaceuticals' Other Working Capital Changes had a median value of $851,000 in 2023 and averaged $848,727.
  • Within the past 5 years, the most significant YoY rise in Day One Biopharmaceuticals' Other Working Capital Changes was 307.05% (2023), while the steepest drop was 230.81% (2023).
  • Over the past 4 years, Day One Biopharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$567,000 in 2022, then surged by 307.05% to $1.2 million in 2023, then crashed by 77.51% to $264,000 in 2024, then tumbled by 133.22% to -$480,000 in 2025.
  • Its last three reported values are -$480,000 in Q3 2025, $1.1 million for Q2 2025, and $606,000 during Q1 2025.